Skip to main content
DOCHealthpeak Properties, Inc.Hold5.6·$20.88+0.34%
HoldModerate Confidence
Investment thesis

Healthpeak Properties has exceeded its analyst consensus target, leaving no positive asymmetry at current levels; while the portfolio demonstrates strong cash conversion and a high financial health score, heavy geographic concentration in San Francisco laboratory space and a dividend whose safety is in question make this a name to reduce rather than add.

Thesis pillars

  • Sf Lab Portfolio ConcentrationDeteriorating
  • Price Above Analyst TargetImproving
  • Dividend Safety ConcernImproving
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Healthpeak Properties, Inc. (DOC) Stock Analysis

HoldGrowthModerate Confidence

Real Estate · REIT - Healthcare Facilities

Hold if already holding. Not a fresh buy at $20.88, but acceptable to hold if already in. Reasons: Concentration risk — Geographic: San Francisco lab portfolio (59.0%); Analyst target reached - limited upside remaining.

Healthpeak Properties is a healthcare REIT owning 689 properties across outpatient medical (507 buildings), lab (145 buildings), and senior housing (34 communities) segments in the U.S. Revenue comes from leases to healthcare providers, biotech tenants, and RIDEA-structured... Read more

$20.88-1.0% A.UpsideScore 5.6/10#8 of 16 REIT - Healthcare Facilities
QualityF-score8 / 9FCF yield11.16%
IncomeYield5.86%(5y avg 5.57%)Payout348.58%
Stop $19.85Target $22.49(resistance)A.R:R -0.2:1
Analyst target$22.87+9.5%19 analysts
$22.49our TP
$20.88price
$22.87mean
$17
$29

Hold if already holding. Not a fresh buy at $20.88, but acceptable to hold if already in. Reasons: Concentration risk — Geographic: San Francisco lab portfolio (59.0%); Analyst target reached - limited upside remaining. Chart setup: No clear chart pattern; technical signals are mixed. Multiple concerning factors. Consider reducing position. | News modifier +1 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Score 5.6/10, moderate confidence.

Passes 6/8 gates (clean insider activity, no SEC red flags, news boost analyst 0.50, earnings proximity 68d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: moderate.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-08-15
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Oct 22, 202668d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Positive news sentiment (+0.89)
Strong growth profile
Risks
Concentration risk — Geographic: San Francisco lab portfolio (59.0%)
Analyst target reached - limited upside remaining
Leverage penalty (D/E 1.1): -0.5

Key Metrics

P/E (TTM)59.4
P/E (Fwd)-138.6
Mkt Cap$14.7B
EV/EBITDA15.7
Profit Mgn8.2%
ROE3.0%
Rev Growth11.1%
Beta1.00
Dividend5.86%
Rating analysts26

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C0.36bullish
IV84%elevated
Max Pain$30+43.7% vs spot

Concentration Risks(10-K Item 1A)

  • LOWTenantHCA Healthcare7.0%
    10-K Item 1: 'most significant outpatient medical tenant concentration ... HCA Healthcare, Inc. (HCA)| | 15 | %| | 7 | %'
  • HIGHGeographicSan Francisco lab portfolio59%
    10-K Item 1: 'including San Francisco, California (59%), Boston, Massachusetts (22%), and San Diego, California (17%) (based on total square feet)'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Macd
0.0
Volume
0.0
Obv
1.6
Ma Position
4.0
Rsi
8.1
Oversold in uptrend (RSI 28)Volume distribution (falling OBV)Above 200-day MA
GatesMomentum 2.7<4.5A.R:R -0.2=NEGATIVEInsider activity: OKNo SEC red flagsNEWS BOOST ANALYST 0.50EARNINGS PROXIMITY 68d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Moderate
RSI
28 · Oversold
20D MA 50D MA 200D MAGOLDEN CROSSSupport $20.46Resistance $22.95

Price Targets

$20
$22
A.Upside-1.0%
A.R:R-0.2:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-1.0% upside)
! NEWS_MOD=+1: SELL_IF_HOLDING → HOLD_IF_HOLDING
! momentum at 2.7 (below the engine's 4.5 threshold)

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-10-22 (68d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is DOC stock a buy right now?

Hold if already holding. Not a fresh buy at $20.88, but acceptable to hold if already in. Reasons: Concentration risk — Geographic: San Francisco lab portfolio (59.0%); Analyst target reached - limited upside remaining. Chart setup: No clear chart pattern; technical signals are mixed. Multiple concerning factors. Consider reducing position. | News modifier +1 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Target $22.49 (+7.7%), stop $19.85 (−5.2%), A.R:R -0.2:1. Score 5.6/10, moderate confidence.

What is the DOC stock price target?

Take-profit target: $22.49 (-1.0% upside). Target $22.49 (+7.7%), stop $19.85 (−5.2%), A.R:R -0.2:1. Stop-loss: $19.85.

What are the risks of investing in DOC?

Concentration risk — Geographic: San Francisco lab portfolio (59.0%); Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.1): -0.5.

Is DOC overvalued or undervalued?

Healthpeak Properties, Inc. trades at a P/E of 59.4 (forward -138.6). TrendMatrix value score: 4.7/10. Verdict: Hold.

What do analysts say about DOC?

26 analysts cover DOC with a consensus score of 3.5/5. Average price target: $23.

What does Healthpeak Properties, Inc. do?Healthpeak Properties is a healthcare REIT owning 689 properties across outpatient medical (507 buildings), lab (145...

Healthpeak Properties is a healthcare REIT owning 689 properties across outpatient medical (507 buildings), lab (145 buildings), and senior housing (34 communities) segments in the U.S. Revenue comes from leases to healthcare providers, biotech tenants, and RIDEA-structured senior housing operators; 2025 Adjusted NOI: outpatient medical $796M, lab $567M, senior housing $177M.

Related stocks: OHI (Omega Healthcare Investors, Inc) · AHR (American Healthcare REIT, Inc.) · VTR (Ventas, Inc.) · SBRA (Sabra Health Care REIT, Inc.) · MPT (Medical Properties Trust, Inc.)
Home Stocks DOC

Latest news

Latest News

MarketWatch17d ago
TradingView17d agoEarnings
TradingView10d ago
Yahoo Finance10d ago
Investing.com South Africa11d ago
MarketWatch18d ago
Investing.com South Africa18d ago
Investing.com18d ago
MarketBeat18d agoEarnings
Seeking Alpha18d ago
GuruFocus109d agoAnalyst
MarketBeat109d ago
MarketBeat109d agoAnalyst
Seeking Alpha102d ago
MarketBeat11d agoEarnings
TipRanks11d ago
Seeking Alpha11d ago
GuruFocus11d agoEarnings
Marketscreener.com11d agoEarnings
Marketscreener.com11d agoEarnings
Loading more...